Australasian Science: Australia's authority on science since 1938

Infographic: how much does Australia spend on science and research?

By Merlin Crossley, Deputy Vice-Chancellor Education and Professor of Molecular Biology, UNSW Australia

CSIRO has received significant cuts to its budget over the past several years. David McClenaghan, CC BY

The election is rapidly approaching, and all major parties – Liberal, Labor and Greens – have now made announcements about their policies to support science and research.

But how are we doing so far? Here we look at the state of science and research funding in Australia so you can better appreciate the policies each party has announced.

The latest OECD figures show that Australia does not fare well compared with other OECD countries on federal government funding research and development.

As a percentage of GDP, the government only spends 0.4% on research and development. This is less than comparable nations.


But looking at total country spending on research and development, including funding by state governments and the private sector, the picture is not so bleak: here Australia sits in the middle among OECD countries.


Over the years, there have been hundreds of announcements and new initiatives but this graph indicates that, in general, it has been a matter of rearranging the deck chairs rather than committing to strategic investments in research.

The Paul Keating Labor government made some investments. During the John Howard Liberal government’s years, there were ups and downs. The Kevin Rudd/Julia Gillard Labor governments were mostly up. And in Tony Abbott’s Liberal government, the graph suggests that it was mostly down with science.


Over the past decade, there have been some minor changes in funding to various areas, although energy has received the greatest proportional increase.


This pie chart reminds us that the higher education sector is a major provider of research and is highly dependent on government funding. It also tells us that business also conducts a great deal of research.


The timeline below shows that the government does listen and respond when issues arise. It has recognised the importance of the National Collaborative Research Infrastructure Scheme (NCRIS), the Australian Synchrotron and sustainable medical research funding by different initiatives.

But, sadly, one must remember that funding is effectively being shifted from one domain to another, and it has seldom been the case that significantly new commitments are made. The balance of red and blue shows how one hand gives while the other takes funding away.


This useful graph highlights the fact that Australian Research Council (ARC) funding now amounts to little more than the National Health and Medical Research Council’s funding.

This is remarkable, given that the ARC funds all disciplines, including sciences, humanities and social sciences, while the NHMRC essentially focuses on human biology and health.


This graphic also highlights the lack of any sustained funding strategy. The only clear trend is that the investment in the ARC has gradually declined and the NHMRC has grown.

This, in part, reflects the undeniable importance of health research. But it is also indicative of effective and coherent organisation and communication by health researchers. This has been more difficult to achieve in the ARC space with researchers coming from a vast array of disciplines.


The Conversation

Merlin Crossley works for the University of New South Wales and receives funding from the Australian Research Council and National Health and Medical Research Council. He is on the Trust of the Australian Museum, and the Boards of the Sydney Institute of Marine Science, UNSW Global, and UNSW Press, he is also an Editorial Board Member of The Conversation.

Les Field receives research funding from the Australian Research Council. He is a member of the senior Executive of the University of New South Wales in Sydney. He is a Council Member and the Secretary for Science Policy for the Australian Academy of Science. He is a Director of Uniseed which is a company that invests in early stage technology and a director of ATPI which is an incubator for early stage companies. He is a Director of the Victor Chang Cardiac Research Centre.

Originally published in The Conversation.